EP300 and hepatocellular carcinoma: Previous studies suggest that high expression of the transcriptional coactivator EP300 correlates with aggressive features of hepatocellular carcinoma and cutaneous squamous cell carcinoma (Li et al., 2011; Chen et al., 2015).